Luqman Ibrahim Malaysia
Dr Luqman is a consultant endocrinologist at the Regency Specialist Hospital (RSH), and a visiting consultant at the Universiti Malaya Medical Center (UMMC). His main clinical area of expertise is on the management of type 1 diabetes, diabetes technologies, as well as type 2 diabetes and general endocrinology. He is currently the head of Diabetes Care Unit in RSH and runs the type 1 diabetes Transition Clinic in UMMC.
Dr Luqman is a council member of the Malaysian Endocrine and Metabolic Society (MEMS), Malaysian Osteoporosis Society (MOS), and a member of the Malaysian Diabetes Educators' Society (MDES) and Malaysian Obesity Society (MyOS).
22 MARCH
| Time | Session |
|---|---|
|
14:00
15:30
|
Jae Hoon MoonSouth Korea
Moderator
A New Era of Managing Thyroid Eye Disease: AI-Based Quantitative Monitoring and Precision CareThyroid Eye Disease (TED) is the most common extrathyroidal manifestation of autoimmune thyroid dysfunction, occurring in approximately 30% to 50% of patients with Graves’ disease. While endocrinologists primarily manage thyroid dysfunction, TED can severely impact a patient’s quality of life through vision loss, diplopia, and cosmetic concerns, necessitating active early intervention. Consequently, it is crucial for clinicians to be proficient in basic TED assessments for early diagnosis; however, many endocrinologists remain unfamiliar with these evaluations, which often leads to delayed treatment.
To usher in a new era of managing TED, a paradigm shift toward AI-based quantitative monitoring and precision care is explored in this session. Fundamental assessment methods, including the Clinical Activity Score (CAS), exophthalmos, and Margin-Reflex-Distance 1 (MRD1), will be introduced alongside clinical cases where AI-driven solutions provide objective and reproducible data. These cutting-edge tools go beyond simple diagnostic assistance by quantitatively tracking disease progression and treatment response, thereby facilitating highly personalized treatment plans. By integrating these innovative AI solutions, a comprehensive approach to TED management is presented, demonstrating how technology and innovation converge to solve long-standing clinical challenges and improve patient outcomes.
201AF
|